As of 4:00pm ET
| +0.05 / +0.31%|
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
|Stephen S. Tang||Chairman, President & Chief Executive Officer|
|Ronald H. Spair||Director, Chief Operating & Financial Officer|
|Michael Reed||Chief Science Officer, SVP-Research & Development|
|Jack E. Jerrett||Secretary, Senior Vice President & General Counsel|
|Kathleen G. Weber||Senior Vice President & GM-Consumer Products|